Blood vessels sustain every organ, and vascular dysfunction drives major cardiovascular, neurological, renal, pulmonary, and oncology diseases. CELLnTEC’s xeno-free endothelial cell culture media power advanced vascular models, reproducible angiogenesis assays, and clinically upgradable workflows. These scalable in vitro systems enable high-quality endothelial expansion and functional stability for predictive translational cardiovascular and blood–brain barrier research.
Endothelial cells form the inner lining of blood and lymphatic vessels and regulate vascular homeostasis, angiogenesis, permeability, and barrier function. Through control of nutrient exchange, immune trafficking, and vascular tone, endothelial biology directly influences inflammation and organ function. High-fidelity endothelial models are therefore essential for mechanistic studies, target validation, and translational vascular biology.
Dysregulated endothelial biology underlies atherosclerosis, coronary artery disease, hypertension, stroke, diabetic vasculopathy, retinopathy, chronic kidney disease, pulmonary hypertension, and cancer-driven tumor angiogenesis. High-fidelity vascular models that reproduce barrier integrity, angiogenic behavior, and clinically relevant phenotypes are critical for understanding disease mechanisms and developing next-generation therapies.
CELLnTEC provides specialty, xeno-free endothelial media optimized for isolation, rapid expansion, and functional analysis of primary human endothelial cells, including HUVECs. Our systems maintain a preserved endothelial phenotype with correct VE-Cadherin localization and robust tube formation capability—key parameters for vascular network formation, permeability assays, and validated angiogenesis readouts. Performance is designed for reproducibility across donor sources and workflows.
From basic vascular biology to drug discovery and assay development, our endothelial barrier systems and angiogenesis models support scalable in vitro pipelines. Whether building vascular constructs, optimizing endothelial phenotyping, or advancing cardiovascular and blood–brain barrier research, CELLnTEC enables reliable, functional, and clinically relevant translational outcomes.
Human-relevant microvascular endothelial cell models.
Sustains expression of key endothelial markers in culture for reliable data interpretation.
Enables long-term culture while retaining endothelial identity, morphology, and function.
Maintains correct VE-Cadherin junctional localization for barrier-relevant studies.
Supports both traditional monolayers and advanced 3D or organotypic vascular models.
3D vascularized tissue constructs, vascular graft, and scaffold endothelialization.
Lymphatic endothelial research on edema, immune cell trafficking, and metastasis.
HUVEC culture for vascular signaling pathways, inflammation, and permeability studies.
Immuno-endothelial interaction assays, including leukocyte adhesion and transmigration.
Tube formation assays for robust angiogenesis readouts.
Shear-stress and flow-based endothelial mechanobiology experiments.
Diabetic vasculopathy and endothelial dysfunction studies.
High-content screening of pro- and anti-angiogenic compounds.
Coronary artery and peripheral vascular disease.
Vascular toxicity and safety pharmacology assessment.
1
Xeno-free formula to align with 3R principles and for projects moving toward clinical and GMP environments.
3
Tailored for primary human endothelial cells sourced from multiple vascular beds.
2
A single proprietary base medium underpins isolation, expansion, and differentiation phases.
4
One-bottle, one-step preparation simplifies daily endothelial culture routines.
Primary epithelial cells growing in CnT-NX-EX display a highly proliferative phenotype. For differentiation experiments, it is recommended to switch to the CnT-PR-D or CnT-PR-3D differentiation media.
